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Abstract
Background: Endometrial cancer is the fourth most common cancer in European women. The major risk factors for
endometrial cancer are related to the exposure of endometrium to estrogens not opposed to progestogens, that can
lead to a chronic endometrial inflammation. Diet may play a role in cancer risk by modulating chronic inflammation.
Methods: In the framework of a case-control study, we recruited 297 women with newly diagnosed endometrial
cancer and 307 controls from Northern Italy. Using logistic regression, we investigated the role of fruit and vegetable
intake, adherence to the Mediterranean diet (MD), and the dietary inflammatory index (DII) in endometrial cancer risk.
Results: Women in the highest quintile of vegetable intake had a statistically significantly lower endometrial cancer risk
(adjusted OR 5th quintile vs 1st quintile: 0.34, 95% CI 0.17-0.68). Women with high adherence to the MD had a risk of
endometrial cancer that was about half that of women with low adherence to the MD (adjusted OR: 0.51, 95% CI 0.39-
0.86). A protective effect was detected for all the lower quintiles of DII, with the highest protective effect seen for the
lowest quintile (adjusted OR 5th quintile vs 1st quintile: 3.28, 95% CI 1.30-8.26).
Conclusions: These results suggest that high vegetable intake, adherence to the MD, and a low DII are related to a
lower endometrial cancer risk, with several putative connected biological mechanisms that strengthen the biological
plausibility of this association.
Keywords: Endometrial cancer, Fruits and vegetables, Mediterranean diet, Dietary inflammatory index, Case-control
study
Introduction
Endometrial cancer is the fourth most common cancer
in European women, [1] with about 56,000 new cases
diagnosed in 2008. [2] The major risk factor for endo-
metrial cancer is an unbalanced and/or prolonged
exposure of the endometrium to oestrogens. Indeed, ex-
posure to endogenous or exogenous oestrogens not
opposed by progestogens leads to an increase in the
mitotic activity of endometrial cells, resulting in an in-
crease in DNA replication and an increased probability
of somatic mutations [3]. Such unbalanced or prolonged
exposure can occur in women who experience late
menopause, are nulliparous, have polycystic ovary syn-
drome, take oestrogen replacement therapy (without
progestogens), or are overweight/obese [3].
Furthermore, the hormonal regulation of the growth
and shedding of the endometrial mucosa during the
menstrual cycle is associated with endometrial inflam-
mation, [4]. which can be aggravated by hormonal
deregulation. Chronic endometrial inflammation is also
* Correspondence: carlotta.sacerdote@cpo.it
4Unit of Cancer Epidemiology, Città della Salute e della Scienza
University-Hospital and University of Turin, Via Santena 7, Turin, Italy
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ricceri et al. BMC Cancer  (2017) 17:757 
DOI 10.1186/s12885-017-3754-y
associated with overweight and obesity. This raises the
possibility that local inflammation may be a risk factor
in endometrial cancer development, [5] and by exten-
sion, that diet may play a role independently of obesity
by mediating oestrogen levels [3] and/or by modulating
chronic inflammation. The evidence of an association
between endometrial cancer risk and specific dietary
components is limited and includes a publication from
the World Cancer Research Fund, which reported a
probable beneficial association between coffee consump-
tion and endometrial cancer risk, as well as a possible
negative association with glycaemic load [6]. In this con-
ceptual framework, we examined the role of fruit and
vegetable intake, adherence to the Mediterranean diet
(MD), and the dietary inflammatory index (DII) in endo-
metrial cancer risk.
Methods
Subjects
Endometrial cancer cases were recruited at the Turin
University Gynaecological Hospital, where about 70% of
endometrial cancers occurring in the Piedmont Region
of Northwest Italy area are treated. We recruited 297
women who lived in the Piedmont Region (age 40–
74 years) and were newly diagnosed with histologically
confirmed endometrial cancer.
Two sets of controls were recruited: i) a random sam-
ple of females (age 40–74 years) from the Turin centre
of the European Prospective Investigation into Cancer
and Nutrition (EPIC-Turin population controls, N = 98)
[7]; and ii) a hospital-based sample of women (age 40–
74 years) treated at the general university hospital for
minor afflictions not related to diet or to hormonal
status (N = 209). Both control groups were made up of
women residing the Piedmont Region who had not
undergone hysterectomy. The two control groups were
comparable with respect to the distribution of major
confounding factors (data not shown).
The research have been approved by the Human
Genetics Foundation (HuGeF) and University of Turin
ethical committee and all subjects enrolled in the study
signed an informed consent form.
Data collection
The information analyzed in this study was collected
using questionnaires from EPIC Italy: a lifestyle ques-
tionnaire and a validated food frequency questionnaire
(FFQ). Age, age at menarche, parity, oral contraceptive
use, menopausal status, use of hormone replacement
therapy, body mass index (BMI), physical activity (occu-
pational and recreational), education, tobacco smoking
status, diet and education was taken from the EPIC Italy
lifestyle questionnaire [7]. Women were classified as
postmenopausal if they had gone at least 1 year without
any menstrual cycle. Physical activity was categorised as
inactive or moderately inactive (<10 h/week), moderately
active (10–24 h/week), and active (>24 h/week). An
additional, short questionnaire was used to collect more
detailed information on hormonal and reproductive his-
tory and physical activity. The estimated intake and aver-
age portion sizes of up to 260 food items consumed in
the last 12 months was taken from the validated EPIC
Italy FFQ [8]. A matrix for the conversion of food items
into nutrients and micronutrients was applied [9].
A trained interviewer administered the questionnaires
to cases and hospital-based controls during a face-to-
face interview. During the questionnaire interviews,
measures of weight, height, and waist and hip circumfer-
ences were taken for all subjects, and before the begin-
ning of any cancer treatment among cases.
Information on the EPIC-Turin population controls
was taken from the same EPIC Italy questionnaires.
These questionnaires were administered in an identical
manner, and the same anthropometric measures were
taken, but these steps were completed at the time of
enrolment in the EPIC Study.
Dietary indices
The dietary habits of the women included in the study
were summarised in two indices: an MD index and a DII
index. The MD index was constructed based on
women’s adherence to MD as per Trichopoulou et al.,
[10] using food groups recommended by Davidson and
Passmore [11]. The MD index takes into account eight
dietary habits common to the MD: high monounsatu-
rated/saturated fat consumption ratio, high consumption
of legumes, high consumption of cereals (including
bread and potatoes), high consumption of fruits, high
consumption of vegetables, moderate ethanol consump-
tion (less than two glass of wine a day, but not ab-
stainer), low consumption of meat and meat products,
and low consumption of milk and dairy products.
Median values were used as the cut-off (Table 1 Panel
A). Women were divided into three categories according
to the number of habits adopted: low adherence to the
MD (from 0 to 3 habits), moderate adherence to the
MD (from 4 to 5 habits), or high adherence to the MD
(more than 6 habits).
A DII was then derived based on the original DII by
Cavicchia et al [12] and its successive improvement by
Shivappa et al [13]. We evaluated the consumption of
the available items from the FFQ: twenty-four nutrients
(β-carotene, caffeine, carbohydrates, cholesterol, total
energy intake, total fat, fibre, folic acid, ferrum, MUFA,
niacin, N-3 fatty acid, n-6 fatty acid, protein, PUFA,
riboflavin, saturated fat, thiamin, vitamin A, vitamin B6,
vitamin C, vitamin D, vitamin E, and zinc), and three
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Table 1 Data used to build dietary indices. Panel A: Median (IQR) of food or nutrient intakes used as cut-off for the Mediterranean diet
index. Panel B: Mean (SD) of food or nutrient intakes and overall inflammatory effect score used for the dietary inflammation index
Panel A. Mediterranean diet index
Food group or nutrient (g/day) Median (IQR) Score
Legumes 81.40 (54.80–127.20) +1 above the median
Cereals 74.70 (40.90–133.90) +1 above the median
Fruits 253.20 (184.60–345.60) +1 above the median
Vegetables 81.40 (54.80–127.20) +1 above the median
Meat and meat products 100.20 (68.70–134.30) +1 below the median
Milk and dairy products 148.70 (58.30–227.10) +1 below the median
Monounsaturated/saturated fat ratio 1.45 (1.25–1.69) +1 above the median
Ethanol consumption 9.60 (0.00–125.00) + 1 not abstainer and less than 24 g/day
Panel B, dietary inflammation index
Food group or nutrient Mean (SD) Overall inflammatory effect score
β-Carotene (μg) 3166.13 (1783.27) −0.584
Caffeine (g) 35.91 (23.24) −0.124
Carbohydrate (g) 218.48 (80.03) 0.109
Cholesterol (mg) 311.08 (129.26) 0.347
Energy intake(Kcal) 1825.98 (565.17) 0.180
Total fat (g) 73.35 (25.33) 0.298
Fibre (g) 18.80 (6.19) −0.663
Folic Acid (μg) 253.26 (88.03) −0.207
Ferrum (mg) 11.67 (3.49) 0.032
Garlic (g) 2.90 (2.95) −0.412
MUFA (g) 35.70 (12.66) −0.019
Niacin(mg) 15.57 (4.68) −1.00
N-3 Fatty acid (g) 1.08 (0.38) −0.436
n-6 Fatty acid (g) 7.10 (3.28) −0.159
Onion 8.71 (7.91) −0.301
Protein(g) 75.44 (23.16) 0.021
PUFA (g) 8.76 (3.72) −0.337
Riboflavin (mg) 1.39 (0.48) −0.727
Saturated fat (g) 24.74 (9.95) 0.429
Tea (g) 45.93 (81.72) −0.536
Thiamin (mg) 0.87 (0.27) −0.354
Vitamin A (RE) 1047.19 (683.17) −0.401
Vitamin B6 (mg) 1.64 (0.50) −0.365
Vitamin C (mg) 134.39 (68.63) −0.424
Vitamin D (μg) 2.38 (1.22) −0.446
Vitamin E (mg) 7.41 (2.93) −0.419
Zinc (mg) 10.37 (3.43) −0.313
IQR interquartile ratio, SD standard deviation
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available food items (garlic, onion, and tea), and we
weighted their intake using the overall inflammatory
effect scores as computed by Shivappa et al [13] (Table 1
Panel B).
Statistical analyses
Preliminary data analysis was performed using the mean
and standard deviation (SD) or the frequency and percent-
age for quantitative or qualitative variables, respectively.
The intake of fruits and vegetables was divided into quin-
tiles of consumption (using the distribution of controls).
We used the Wilcoxon rank sum test with continuity
correction and the Chi-squared test to determine differ-
ences in general factors and in food and nutrient groups
between cases and controls. Odds ratios (OR) and corre-
sponding 95% confidence intervals (CI) were computed
using unconditional logistic regression models, both uni-
variate and multivariate, adjusting for age, age at menar-
che, parity, oral contraceptive use, menopausal status,
use of hormone replacement therapy, BMI, physical ac-
tivity, education, smoking status, and total energy intake.
Subgroup analyses were also carried out among normal
weight women (i.e., BMI < 25 kg/m2), overweight women
(i.e., BMI 25–30 kg/m2), and obese women (i.e., BMI
>30 kg/m2), and sensitivity analyses were performed among
the two control groups to exclude discrepancies in the re-
sults obtained for these groups. All the analyses were per-
formed using SAS V9.2 package (SAS Inc., Cary, NC, USA).
Results
Cases (N = 297) and controls (N = 307) were comparable
with respect to age, with a mean age at interview of
61.49 (SD 7.48) years for cases and 60.40 (SD 7.72) years
for controls. The group of endometrial cancer cases
included more nulliparous women (15.41% vs 5.61%)
when compared to controls, as well as fewer patients
with a parity ≥2 (6.45% vs 21.05%). Among endometrial
cancer cases there was a higher percentage of women
with lower education (40.94% with primary school or
less vs 27.27% for controls) and a slightly higher percent-
age of never-smokers (67.99% vs 61.15%). Among con-
trols there was a lower percentage of postmenopausal
women (83.89% vs 93.93% for cases), a lower mean age
at menarche (12.51 years, SD 1.51 vs 12.75 years, SD
1.53), and a lower mean BMI (26.61 kg/m2, SD 16.82 vs
28.01 kg/m2, SD 5.90). Parity (p-value < 0.0001), meno-
pausal status (p-value = 0.0001), BMI (p < 0.0001), and
education (p-value = 0.001) showed the most evident
differences (Table 2).
We found a highly significant (p < 0.0001) lower vegetable
intake among cases (mean 85.24 g/day, SD 50.62) with re-
spect to controls (mean 112.24 g/day, SD 74.49) and a less
pronounced, lower fruit intake (mean 262.87 g/day, SD
140.98 vs mean 289.35 g/day, SD 146.28), while no
Table 2 Distribution of characteristics among endometrial
cancer cases and controls (means and standard deviation or
frequencies and percentages)
General characteristics Cases Controls p-valuea
(n = 297) (n = 307)
Age (years) 61.49 (7.48) 60.40 (7.72) 0.10
Age at menarche (years) 12.75 (1.53) 12.51 (1.51) 0.53
Parity <0.001
0 43 (15.41%) 16 (5.61%)
1 218 (78.14%) 209 (73.33%)
≥ 2 18 (6.45%) 60 (21.05%)
Oral contraceptive use 0.39
Yes 53 (19.00%) 65 (21.89%)
No 226 (81.00%) 232 (78.11%)
Menopausal status 0.0001
Postmenopausal 263 (93.93%) 250 (83.89%)
Premenopausal 17 (6.07%) 48 (16.11%)
Hormone replacement therapy 0.36
Yes 52 (18.64%) 64 (21.62%)
No 227 (81.36%) 232 (78.38%)
Body mass index (kg/m2) <0.001
< 25 (normal weight) 107 (36.03%) 163 (53.09%)
25–30 (overweight) 95 (31.99%) 98 (31.92%)
> 30 (obese) 95 (31.99%) 46 (14.98%)
Physical activity 0.08
Inactive or moderately
inactive
28 (10.22%) 47 (16.10%)
Moderately active 161 (58.76%) 169 (57.88%)
Active 85 (31.02%) 76 (26.03%)
Education 0.001
Primary school or less 113 (40.94%) 81 (27.27%)
Secondary or vocational
school
106 (38.41%) 125 (42.09%)
High school or more 57 (20.65%) 91 (30.64%)
Smoking status 0.04
Never smoker 189 (67.99%) 181 (61.15%)
Former smoker 68 (24.46%) 73 (24.66%)
Current smoker 21 (7.55%) 42 (14.19%)
Alcohol consumption (g/day) 6.91 (9.81) 5.87 (9.95) 0.56
Fruit consumption (g/day) 262.87
(140.98)
289.35
(146.28)
0.03
Vegetable consumption (g/day) 85.24 (50.62) 112.24
(74.49)
<0.0001
Total energy intake (Kcal/day) 7569 (2319) 7706 (2408) 0.60
Mediterranean diet index 0.0003
Low adherence
(0–3 habits)
158 (53.20%) 115 (37.46%)
Moderate adherence
(4–5 habits)
111 (37.37%) 143 (46.58%)
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association was found with alcohol intake or total energy
intake (Table 2).
A significant protective effect was found for high vege-
table intake (adjusted OR 5th quartile vs 1st quartile:
0.34, 95% CI 0.17–0.68, p-value for trend = 0.0003), and
a possible protective effect of high fruit intake was
suggested (adjusted OR 5th quartile vs 1st quartile: 0.55,
95% CI 0.28–1.06, p-value for trend = 0.08). Both moder-
ate (adjusted OR: 0.57, 95% CI 0.39–0.86) and high (ad-
justed OR: 0.51, 95% 0.28–0.92) adherence to the MD
resulted in a reduction in endometrial cancer risk of about
50%. A borderline trend (p-value = 0.06) of increasing risk
for increasing DII was found, with highly significant
results obtained for the 2nd, 3rd, and 4th quintiles with
respect to the 1st quintile (Table 3).
Both the subgroup analyses in normal weight, overweight,
and obese women (Additional file 1: Table S1) and the
Table 2 Distribution of characteristics among endometrial
cancer cases and controls (means and standard deviation or
frequencies and percentages) (Continued)
General characteristics Cases Controls p-valuea
High adherence (6–8 habits) 28 (9.43%) 49 (15.96%)
Dietary index of inflammation 0.33
1st quintile (low
inflammation)
46 (16.49%) 69 (23.31%)
2nd quintile 56 (20.07%) 59 (19.93%)
3rd quintile 57 (20.43%) 58 (19.59%)
4th quintile 60 (21.51%) 55 (18.58%)
5th quintile (high
inflammation)
60 (21.51%) 55 (18.58%)
aWilcoxon or Chi-squared test
Table 3 Odds ratios (OR) and 95% confidence Intervals (CI) by fruit and vegetable quintiles, Mediterranean diet index, and dietary
inflammation index quintiles
Crude ORa 95% CI Adjusted ORb 95% CI
FRUIT
1st quintile Reference – Reference –
2nd quintile 0.85 0.52–1.39 0.73 0.41–1.28
3rd quintile 0.71 0.43–1.18 0.60 0.33–1.09
4th quintile 0.77 0.45–1.27 0.66 0.36–1.21
5th quintile 0.54 0.32–0.92 0.55 0.28–1.06
p-value for trend 0.03 0.08
VEGETABLES
1st quintile Reference – Reference –
2nd quintile 1.18 0.73–1.89 1.11 0.65–1.92
3rd quintile 0.58 0.35–0.98 0.55 0.31–0.98
4th quintile 0.65 0.39–1.08 0.58 0.31–1.05
5th quintile 0.29 0.16–0.52 0.34 0.17–0.68
p-value for trend <0.0001 0.0003
MEDITERRANEAN DIET INDEX
Low adherence (0–3 habits) Reference – Reference –
Moderate adherence (4–5 habits) 0.58 0.40–0.82 0.57 0.39–0.86
High adherence (6–8 habits) 0.43 0.25–0.72 0.51 0.28–0.92
p-value for trend 0.0002 0.004
DIETARY INDEX OF INFLAMMATION
1st quintile Reference – Reference –
2nd quintile 1.62 0.94–2.80 2.77 1.41–5.44
3rd quintile 1.51 0.85–2.62 2.44 1.17–5.09
4th quintile 1.73 1.01–2.97 3.03 1.35–6.76
5th quintile 1.79 1.04–3.07 3.28 1.30–8.26
p-value for trend 0.06 0.06
aunivariate analysis
bmultivariate logistic regression models adjusted for age, parity, menopausal status, hormone replacement therapy use, oral contraceptive use, body mass index,
age at menarche, physical activity, education, smoking status, and total energy intake
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sensitivity analyses among the two control groups (data not
shown) showed the same trends we observed in our princi-
pal analyses, with a lower statistical significance due to the
reduction in sample size.
Discussion
In the present study, we analysed the possible role of
diet in the incidence of endometrial cancer. In particular,
we explored the role of dietary patterns that may mediate
oestrogen levels and modulate chronic inflammation.
High vegetable intake, high adherence to the MD and DII
showed a protective effect on endometrial cancer risk.
These results are in agreement with previous studies
[14, 15] and show a clear protective effect of vegetable
intake on endometrial cancer risk and a less compelling
protective effect of fruit intake. Vegetables, and in par-
ticular non-starchy vegetables, may protect from cancer
through modulation of steroid hormone concentrations
and metabolism, activation of antioxidant mechanisms,
modulation of detoxification enzymes, and stimulation
of the immune system [16, 17].
We used two validated dietary indices under the
hypothesis that the use of such indices, which take into
account the interactions among various combinations of
foods and nutrients, could be a stronger determinant of
endometrial cancer risk than any single dietary compo-
nent. The MD is rich in phytoestrogens, agents with
oestrogen-like effects that may compete with oestrogens
in binding to oestrogen receptors, thus exerting antioes-
trogenic effects [18]. Furthermore, the MD contains
several antioxidants with important anti-inflammatory
properties that have been inversely related with cancer
risk in previous case-control studies [19].
Despite mixed results from a recent meta-analysis, which
could not demonstrate an association between significantly
lower endometrial cancer risks and higher adherence to
the MD, [20] our study supports the evidence for a protect-
ive effect of the MD on endometrial cancer risk.
A clear protective effect of a lower DII was observed
in this study. Previous studies have indicated that foods
such as coffee and vegetables are inversely related to
endometrial cancer risk, and are thus consistent with the
hypothesis that an antioxidant diet could be positively
involved in cancerogenesis. All these dietary factors con-
tribute to lower DII values, while animal products, satu-
rated fat acids, and starches contribute to higher DII
values. A recent, large case-control study showed a posi-
tive association between DII and endometrial cancer
[20]. In particular, the authors found that the OR for
women in the highest quartile of DII versus women in
the lowest quartile was 1.46 (95% CI 1.02–2.11) with a
p-value for trend of 0.04.
Inflammation has been related to endometrial cancer
both in cohort and case-control studies. In the EPIC
study and in the Women’s Health Initiative, C-reactive
protein (CRP) and other pro-inflammatory cytokines
(such as IL1 receptor antagonist) were found to be posi-
tively associated with endometrial cancer [21–23].
Consumption of pro-inflammatory foods (such as ani-
mal products) seems to increase CRP levels [24]. This
can cause chronic subclinical inflammation which may
lead to an increase in insulin resistance, [25] which in
turn could be responsible for the stimulation of cell pro-
liferation and the inhibition of apoptosis [3].
The present study has some limitations that are inher-
ent to the case-control design. Potential selection and
information bias should be considered. The participation
rate for both cases and controls was higher than 95%,
and we excluded all women with diagnoses that could be
related to known risk factors for endometrial cancer
from the control group, as well as patients with previous
hysterectomy. Recall bias was possible due to the case-
control design; however the hypothesis of a dietary aeti-
ology for endometrial cancer is not well known in the
general population. The comparability of recall between
cases and the hospital-based controls was improved by
interviewing them in a hospital setting. In spite of these
limitations, the study has some strengths, such as accur-
ate exposure assessment with a validated questionnaire,
and the possibility to adjust the analysis for several
known confounders.
In conclusion, the present case-control study provided
some evidence that high vegetable intake, adherence to
the MD, and a low DII are related to a lower endometrial
cancer risk, with several putative connected biological
mechanisms that strengthen the biological plausibility of
this association.
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